25 August 2026 Clinical Diabetes Coming up: Continuous glucose monitoring update – why it will soon become standard care
30 July 2026 Clinical Diabetes Obesity Pharmaceuticals Tirzepatide dose reduction and the impact on long-term maintenance of weight loss
30 June 2026 Clinical research Diabetes Obesity Pharmaceuticals Triple hormone receptor agonist improves glycaemic control and bodyweight reduction in T2D
19 June 2026 Clinical Diabetes Obesity Pharmaceuticals Tirzepatide KwikPen update: Practical guidance for clinicians